3D Cell Culture 2017

Date: 22-Feb-17 to 23-Feb-17
Location: Copthorne Tara Hotel / London / United Kingdom
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

Following the success of the sell-out Cell Based Assay series, SMi Group is delighted to launch its inaugural conference on 3D Cell Culture which takes place on the 22nd and 23rd of February 2017 in London.

The event is designed to address current and emerging applications of 3D cell culture, providing a platform for industry experts and clinical specialists within drug discovery, toxicology, stem cells, disease modelling and emerging technologies, to discuss the challenges and future directions of this technique.

With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine.

The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culture.

EXPERT SPEAKERS INCLUDE:
# Stefan Przyborski, Professor of Cell Technology, University of Durham
# Louisse Bisset, Senior Biologicals Quality Assessor, MHRA
# Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi-Aventis
# Rasdoslaw Polanski, Senior Research Scientist, AstraZeneca
# Robert Vries, Managing Director, Hubrecht Organoid Technology Foundations
# Olaf Galuba, Scientist, Novartis
# Christopher Schofield, Investigator, GlaxoSmithKline

and more!

For more information and to register, visit www.3D-cellculture.com/evvnt

Exhibitors

Durham University, MHRA, Sanofi, Sanofi Aventis, AstraZeneca, Novartics, GlaxoSmithKline, Lonza

Go to event website